Immediate Impact
1 from Science/Nature 57 standout
Citing Papers
Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
2024 Standout
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Works of L. Feuvret being referenced
Cognitive impairment and morphological changes after radiation therapy in brain tumors: A review
2018
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| L. Feuvret | 545 | 468 | 219 | 78 | 1.1k | |
| Stéphanie Bolle | 432 | 402 | 158 | 93 | 972 | |
| Lilia Loredo | 719 | 326 | 255 | 32 | 1.3k | |
| Valentin Calugaru | 672 | 149 | 143 | 87 | 1.2k | |
| C. Ares | 742 | 188 | 209 | 38 | 1.2k | |
| Ronny L. Rotondo | 752 | 380 | 112 | 55 | 1.2k | |
| Marina Gardiman | 459 | 722 | 203 | 46 | 1.3k | |
| Petter Brandal | 457 | 518 | 115 | 88 | 1.3k | |
| Elizabeth A. Weyman | 634 | 457 | 91 | 29 | 1.0k | |
| Narendra Kumar | 381 | 519 | 244 | 83 | 915 | |
| Mika Watanabe | 346 | 338 | 148 | 77 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...